Skip to main content
. 2010 Sep 1;1:126–135. doi: 10.7150/jca.1.126

Figure 3.

Figure 3

p16 does not appear to affect breast cancer cell adhesion. The breast cancer cells MDA/Tet-on p16 (or MDA/p16) and MDA/Tet-on GFP (or MDA/GFP) (A) or 4T1/Tet-on p16 (or 4T1/p16) and 4T1/Tet-on GFP (or 4T1/GFP) (B) were incubated with or without 1 μg/ml Dox for 72 h. The cells were then harvested and used for adhesion assay as described in M & M section. The results represent the data from at least two independent experiments, each performed in triplicate. The differences between with and without Dox treatment groups, as well as between Tet-on p16 and Tet-on GFP groups are not significant (p>0.05).